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Abstract
Background: New antibiotic resistance determinants are generally discovered too late, long after they have
irreversibly emerged in pathogens and spread widely. Early discovery of resistance genes, before or soon after their
transfer to pathogens could allow more effective measures to monitor and reduce spread, and facilitate genetics-
based diagnostics.
Results: We modified a functional metagenomics approach followed by in silico filtering of known resistance genes
to discover novel, mobilised resistance genes in class 1 integrons in wastewater-impacted environments. We identified
an integron-borne gene cassette encoding a protein that conveys high-level resistance against aminoglycosides with a
garosamine moiety when expressed in E. coli. The gene is named gar (garosamine-specific aminoglycoside resistance)
after its specificity. It contains none of the functional domains of known aminoglycoside modifying enzymes, but bears
characteristics of a kinase. By searching public databases, we found that the gene occurs in three sequenced, multi-
resistant clinical isolates (two Pseudomonas aeruginosa and one Luteimonas sp.) from Italy and China, respectively, as
well as in two food-borne Salmonella enterica isolates from the USA. In all cases, gar has escaped discovery until now.
Conclusion: To the best of our knowledge, this is the first time a novel resistance gene, present in clinical isolates, has
been discovered by exploring the environmental microbiome. The gar gene has spread horizontally to different
species on at least three continents, further limiting treatment options for bacterial infections. Its specificity to
garosamine-containing aminoglycosides may reduce the usefulness of the newest semisynthetic aminoglycoside
plazomicin, which is designed to avoid common aminoglycoside resistance mechanisms. Since the gene appears to be
not yet common in the clinics, the data presented here enables early surveillance and maybe even mitigation of its
spread.
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Background
Mobile resistance factors accumulate in human patho-
gens via horizontal transfer, often from environmental
bacteria or commensals [1]. To the best of our know-
ledge, every resistance factor that is a clinical problem
today was discovered long after it irreversibly emerged
and spread in pathogenic bacteria widely enough to
cause treatment failures. After discovery, propagation
can often be tracked in retrospect from country to coun-
try. One of the most prominent examples is the first de-
tection of the mobile colistin resistance gene mcr-1 in
2015 followed by documentation of its worldwide pres-
ence [2].
If we could identify new resistance threats before they
spread widely or even before they appear in pathogens,
actions could be taken to reduce the risks of their emer-
gence, spread and clinical consequences. Such actions
include targeted monitoring, confinement and the
addition of the new genes to genetics-based diagnostics.
Moreover, the development of new antibiotics can bene-
fit from the awareness of novel resistance mechanisms.
Large-scale functional screening of metagenomic DNA
from microbial communities has revealed many un-
known resistance genes in various environments [3, 4].
The approach is independent of the cultivability of the
indigenous bacterial host and does not rely on similarity
to known genes, making it suitable for the identification
of novel resistance determinants [5]. Functional metage-
nomics cannot, however, easily discriminate between
mobile and immobile genes, the latter having less poten-
tial of transfer to and between pathogens [6]. Moreover,
common resistance genes will dominate the sequenced
clones, reducing the likelihood of identifying rare, novel
genes.
Integrons are genetic elements that acquire, shuffle
and express promoter-less gene cassettes. Although not
mobile themselves, integrons are often associated with
mobile elements and located on conjugative plasmids
[7]. This combination makes them ideal for acquisition
and spread of resistance genes to and among pathogens,
particularly integrons of class 1 [8].
The aim of this study was to discover rare, novel resist-
ance determinants that may appear in pathogens or that
have already emerged in pathogens but thus far escaped
identification. We explored bacterial communities from
river sediments contaminated with wastewater in a coun-
try with a high use of antibiotics (India) [9] by adapting a
functional metagenomics approach focusing on amplicon
libraries of integron gene cassettes. Blunt-end cloning into
a plasmid under the control of a constitutively active pro-
moter allowed us to screen for resistance against different
antibiotics. To overcome sensitivity limitations, we did not
analyse individual resistant clones but rather amplified
and sequenced inserts of all growing bacteria on the plates
via long-read technologies. We then filtered out highly
abundant known resistance genes in silico to identify rare,
new putative resistance genes.
Results and discussion
To identify mobilised novel resistance determinants,
class 1 integron gene cassette libraries were prepared
under control of the constitutively active Pbla promoter
in E. coli DH10β pZE21-Pbla. Library sizes ranged from
5.0 × 109 to 1.8 × 1010 bp. The estimated average insert
size of all libraries ranged from 600 to 1000 bp. Libraries
were screened for functional resistance determinants on
13 different antibiotics at three different concentrations
(Additional file 5). No resistance against tigecycline or
nitrofurantoin was detected. The other antibiotics re-
sulted in at least 15 to up to several thousand colonies
on each screening plate. All colonies were scraped off
and barcoded amplicons were prepared for long-read se-
quencing (PacBio Sequel). Amplicon sequencing resulted
in 419,709 reads. Based on the retrieved barcodes, 382,
332 could be assigned to the antibiotics and concentra-
tions used to select resistant clones. We then predicted
open reading frames (ORFs) and filtered out all reads
containing known antibiotic resistance genes (ARGs) re-
sponsible for the respective phenotype. Known ARGs
were defined as the ORFs with identity greater than 95%
and coverage greater than 85% to their homologues in
the ResFinder database. The remaining 147,151 reads
consisted of 46,403 unique reads (11% of all reads) with
an average length of 1540 bp and they included 48,562
unique predicted ORFs. Each of the selection amplicons
resulted in an average of 1450 reads with no known
ARGs. These were searched manually for resistance gene
candidates.
To identify promising putative novel resistance genes,
we used five criteria: An ORF needed to be (i) complete
and (ii) highly abundant in its set of reads while (iii) not
common in the other selection sets. To ensure that the
ORF originated from an integron (iv) both binding sites
for the primers used to amplify the gene cassettes should
be present in the read. Furthermore, (v) the candidate
ORF should be the only ORF present that could explain
the resistance phenotype. Despite the large number of
colonies growing during functional selection, only the
gentamicin and β-lactam selection sets contained ORFs
fulfilling all mentioned criteria (Table 1). Thus, the
metagenomic DNA samples used in this study contain
exceptionally high amounts of class 1 integrons carrying
a multitude of antibiotic resistance genes [10, 11], but
most of them were filtered out as known or close vari-
ants of known ARGs.
Using this approach, candidate ORFs with little or no
resemblance to any known resistance factor were chosen
for functional verification. The putative, completely novel
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resistance genes found in the read set selected by β-
lactams did not confer resistance when synthesised and
expressed in E. coli. It is possible that they were able to
grow in close vicinity to resistant colonies during the func-
tional selection, since β-lactamases are secreted into the
periplasm and in outer membrane vesicles to inactivate β-
lactam antibiotics [12–14]. Hence, they might simultan-
eously provide close-range protection for surrounding
non-resistant bacteria, which appeared as false positives.
Resistance of the candidate gene highly selected on
gentamicin (designated gar = garosamine-specific amino-
glycoside resistance) was successfully verified in E. coli.
The protein GAR (167 aa) has an overall negative charge
(pI 4.6). Since cation concentrations profoundly influ-
enced the minimal inhibitory concentrations (MICs)
(Table S1), we performed all subsequent experiments in
cation-adjusted Mueller-Hinton broth. The expression
of gar resulted in a 2760-fold MIC increase of gentami-
cin (Fig. 1).
Aminoglycoside modifying enzymes (AMEs) are the most
clinically important resistance mechanism against amino-
glycosides [15]. AMEs are divided into three enzymatic
classes targeting –OH or –NH2 groups: aminoglycoside N-
acetyltransferases (AACs), –O-nucleotidyltransferases
Table 1 Abundance of candidate ORFs for functional selection
gar ORF 1 ORF 2 ORF 3
Predicted functional domain P-loop NTPase None partial S41-like peptidase DUF1851
Length [bp] 504 816 867 438
Abundance in selection sets cefotaxime 0 416 18 25
chloramphenicol 8 12 0 0
ciprofloxacin 7 5 0 0
colistin 0 10 0 0
ertapenem 8 1 0 14
gentamicin 1692 1 0 2
imipenem 26 1 0 1
meropenem 0 17 0 11
rifampicin 0 5 0 2
sulfamethoxazole 0 2 0 0
trimethoprim 16 1 0 0
ORFs recovered from the set of unique reads were clustered with 97% identity threshold in each selection set. The size of clusters was reported as the abundance
of candidate ORFs
Fig. 1 MIC values of GAR against several aminoglycosides. Molecular structures are shown in Table S2
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(ANTs) and –O-phosphotransferases (APHs). Each
class possesses a unique pattern of activity against dif-
ferent aminoglycosides due to their specific targets in
the molecular structure [16]. We therefore tested the
effectiveness of GAR against at least one representa-
tive of each aminoglycoside subclass (Fig. 1). GAR
conferred resistance specifically against all six tested
4,6-disubstituted 2-deoxystreptamine–aminoglycosides
containing a garosamine residue (Table S2), suggest-
ing that it is critical for recognition.
Aminoglycosides can cause mistranslation by targeting
the negatively charged 16S rRNA close to the
aminoacyl-tRNA site of the 30S subunit [17]. The nega-
tive charge and garosamine-specific resistance pattern
make the ribosomal RNA an unlikely target for GAR.
GAR contains the Walker A NTP-binding motif in-
volved in various phosphorylation reactions [18]. It also
harbours two DxD motifs (Fig. 2). Such a motif provides
the ability to bind the required Mg2+ [18, 23, 26]. The
presence of these two motifs and its negative charge
strongly suggest that GAR is enzymatically active as a
kinase with high affinity for positively charged targets.
Aminoglycosides are indeed positively charged mole-
cules that provide many hydroxyl residues for potential
phosphorylation, including two at the garosamine moi-
ety. One of these hydroxyl groups, located at the 4″ car-
bon atom, has not yet been described as a target for an
AME.
There is very little similarity between GAR and all
known ARGs, including AMEs (less than 20% amino
acid identity). The phylogenetic tree of GAR and related
proteins (Fig. 3) shows that GAR is clearly separated
from the known AMEs and is located among proteins
mostly annotated as hypothetical or AAA-domain con-
taining proteins (kinases). The closest related protein
from the NCBI non-redundant protein database (51%
identity, WP_135484108.1) is not assigned any function.
GAR shares slight amino acid sequence identity (about
20%) to tunicamycin resistance proteins (Fig. 2). Resist-
ance to tunicamycin, a toxic nucleoside analogue pro-
duced by several Streptomyces species, is caused by
ATP-binding membrane proteins, which also have a sus-
pected phosphorylation activity [20, 27].
Several studies have identified a range of new ARGs in
environmental samples [4, 28–32]. However, the clinical
implications are less clear, since only a minor fraction of
these genes are likely to end up in pathogens, e. g. due
to lack of mobility, limited ecological connectivity and
high fitness costs [3, 6]. Searching gar against the Gen-
Bank database resulted in 100% and 99% nucleotide
identity with chromosomal regions of the clinical isolates
Luteimonas sp. 83-4 (CP029556.1, China) and P. aerugi-
nosa 105MG [33] (AJ786649.2, Italy), respectively. We
additionally found gar on contigs of the clinical isolate
P. aeruginosa S742_C15_BS (NFFO01000062.1, Italy)
and on contigs of the food-borne pathogens S. enterica
ADRDL-2811 (AAKHBQ010000151.1, USA) and S.
enterica subsp. enterica serovar Johannesburg
FSIS1609335 (AAIUOI010000042.1, USA) isolated from
poultry products. In neither case was the gar gene recog-
nised as a resistance gene. We can show that gar appears
as a gene cassette in several spatially, temporally and
phylogenetically separated clinical isolates, so the gene
has already overcome the barrier preventing most envir-
onmental ARGs from becoming clinically relevant. Com-
bined with its absence in related isolates (none of the
other currently available P. aeruginosa, Luteimonas sp.
or S. enterica genomes or assemblies in GenBank con-
tain gar), this provides evidence that the gar gene is mo-
bile. Furthermore, P. aeruginosa 105MG and P.
aeruginosa S742_C15_BS belong to the exceptionally
successful multidrug-resistant P. aeruginosa ST235 and
ST111 linages, respectively, which are predominant on
five continents [34]. P. aeruginosa frequently causes
nosocomial infections with high mortality rates, espe-
cially in patients with chronic diseases, due to the accu-
mulation of resistances against aminoglycosides, β-
lactams and fluoroquinolones [34, 35]. Salmonellosis is
the most important food-borne illness in the USA and
the second most common in the EU [36, 37]. Salmonella
isolates have collected a multitude of aminoglycoside re-
sistance genes, probably due to the long-term usage of
this antibiotic class in food production [38]. Occurrence
in several common multidrug-resistant pathogens in-
creases the probability for horizontal gene transfer, (co-)
selection and spread of gar.
The structure-specific resistance pattern of AMEs im-
plies that a single resistance gene cannot confer resistance
against all aminoglycosides. However, any ARG that adds
resistance to any antibiotic, which could have been a treat-
ment possibility, reduces clinical options for treatment.
For instance, P. aeruginosa 105MG carries four AMEs
(aph(3)-IIb, aac(6)-31, ant(3″)-Ia, aac(6)-Il) plus gar, a
combination that results in resistance against all tested
aminoglycosides with the exception of apramycin (Table
S3). The five AMEs target streptomycin/spectinomycin
(ant(3″)-Ia); the –OH(3′) of kanamycin, G418, isepami-
cin, paromomycin and ribostamycin (aph(3)-IIb) and the
–NH2(6′) of kanamycin, gentamicin, netilmicin, sisomicin,
isepamicin, amikacin, tobramycin and ribostamycin
(aac(6)-31, aac(6)-Il) [16]. Thus, even in a strain already
harbouring several AMEs, gar extends the resistance pro-
file (micronomicin). Luteimonas sp. 83-4 contains two
aminoglycoside resistance genes, an aph(3′)-XV and gar
(Table S4). Here, gar adds resistance to gentamicin, netil-
micin, sisomicin and micronomicin, exacerbating already
observed clinical multi-resistance. Resistance against
garosamine-containing aminoglycosides is particularly
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Fig. 2 Structural motifs of GAR and related proteins. a Alignment of GAR with related proteins. The two amino acids that differ between GAR
variants (L9I, T75A) are framed in black. The ORF from Luteimonas sp. 83-4 (CP029556) with 100% identity to GAR has no annotation. OrfPa105
(AJ786649) from P. aeruginosa 105MG and the ORF from P. aeruginosa S742_C15_BS without annotation (NFFO01000062.1) are identical. They
differ by two nucleotides and one amino acid (T75A) from GAR. The two ORFs from S. enterica ADRDL-2811 (AAKHBQ010000151.1) and S. enterica
subsp. enterica serovar Johannesburg FSIS1609335 (AAIUOI010000042.1) are identical to each other, annotated as hypothetical proteins and differ
by two nucleotides and one amino acid (L9I) from GAR. Tunicamycin resistance protein TmrB as harboured by Bacillus subtilis (WP_003246258.1),
the C-terminal membrane anchor is underlined [19], TmrD from Deinococcus radiodurans (WP_010888058.1) [20]. The N-terminal Walker A motif
occurs in TmrB and in GAR, but the absence of the membrane anchor hints to a cytoplasmic location of GAR. The NTP-binding motif G/
AXXGXGKT/S (Walker A or P-loop) is marked by red rectangles [18, 21, 22]. Searching NCBI’s conserved domain database revealed an AAA domain
(ATPases Associated with diverse cellular Activities, pfam13238) within GAR and similarity to gluconate kinases (COG3265). GAR harbours no
Walker B motif, but two potential DxD motifs, which could be responsible for Mg2+ binding [23], marked by blue rectangles. b Protein structure
model of GAR. According to the structure model, the first DxD motif (aa 31–33) is located in the same cavity as the P-loop and thus more likely
to participate in the NTP-binding and hydrolysis. GAR is shorter than other aminoglycoside phosphotransferases (APHs) and seems to contain five
N-terminal parallel β-sheets, while APHs contain five anti-parallel β-sheets in their N-terminal domain [24, 25]
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worrying, since the newest semisynthetic aminoglycoside
plazomicin (FDA-approved for treatment of complicated
urinary tract infections [39]), which is derived from siso-
micin and designed to avoid most of the common AMEs
[40], includes garosamine. In the light of more and more
widespread resistance to e.g. all β-lactams, an increasing
dependence on aminoglycosides presenting a target for
gar implies a growing selective pressure for bacteria to ac-
quire, keep and spread the gar gene.
To examine if gar is present on a conjugative element
in the P. aeruginosa 105MG isolate available to us, we
attempted to transfer its aminoglycoside resistance
phenotype to E. coli or P. putida via conjugation, but
could detect none. Nonetheless, considering that gar is
harboured by three distantly related species, it can obvi-
ously move horizontally. To shed light on the mecha-
nisms involved, the genome of P. aeruginosa 105MG
(GenBank accession: VLOE00000000) was sequenced.
The gar gene is located within a class 1 integron on a
chromosomal scaffold of 1.18Mb. The integron is
flanked by Tn3 and Tn21 transposon elements, which
are highly abundant in bacterial genomes [41–43].
Transposable elements can promote inter-cellular mobil-
ity of integrons by insertion into a conjugative plasmid
or an integrative conjugative element (ICE). The contigs
upstream of the class 1 integron of the two P. aeruginosa
isolates containing the gar gene cassette are identical
and harbour several genes encoding conjugal transfer
proteins. Hence, the entire integron could have been
aquired from a conjugative plasmid/ICE, e.g. via Tn21
[44]. There are currently 261 P. aeruginosa genomes in
NCBI’s database of complete genomes, 74 of them (28%)
contain the complete intI1 gene (query cover and iden-
tity ≥ 97%), ten (4%) of which are plasmid-borne, but
only the 105MG isolate harbours gar. It is thus highly
plausible that gar has been aquired as a cassette, prob-
ably from an integron located on a yet unidentified plas-
mid/ICE hosted transiently by P. aeruginosa 105MG.
We have identified gar in six gene cassette arrays in at
least three species. These regions are within integrons
and adjacent to known resistance gene cassettes, such as
aph(3′)-XV, blaOXA-2 and blaVIM-1, providing resistance
to a range of critically important antibiotics (Fig. 4). The
identified genetic contexts show that gar has appeared
as the first and only gene cassette in the integrons from
PETL metagenomic samples, as the fifth in Luteimonas
sp. 83-4, the third in P. aeruginosa 105MG, the fourth in
P. aeruginosa S742_C15_BS and the first in both S.
enterica isolates. Rearrangement of gene cassettes pro-
vides rapid adaptation in response to changing environ-
ments. The presence of gar in different contexts and
pathogens not only shows that it could confer a selective
Fig. 3 Phylogenetic tree of aminoglycoside resistance enzymes, GAR and its 1000 closest related protein sequences. Clades are collapsed (dark
circles) to improve visual comparisons
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Fig. 4 Gar in the six identified genetic contexts. a PETL metagenomics DNA sample. Primers HS458-HS459 amplified the region between attI site
and qacEΔ of a clinical class 1 integron (GenBank accession MN215968). b Luteimonas sp. 83-4 (CP029556.1), chromosomal, not annotated in the
available contig sequence. c P. aeruginosa 105MG (AJ786649.2 and VLOE00000000), chromosomal, clinical class 1 integron, included in a Tn5051-
like transposon. Gar variant of P. aeruginosa 105MG = orfPa105, previously annotated as hypothetical protein. d P. aeruginosa S742_C15_BS
(NFFO01000062.1), clinical class 1 integron, downstream context identical to P. aeruginosa 105MG, but lacking the Tn21-like region upstream. e S.
enterica subsp. enterica serovar Johannesburg FSIS1609335 (AAIUOI010000042.1), class 1 integron, downstream flanked by Tn21 elements, ISPa38
and IS110. f S. enterica ADRDL-2811 (AAKHBQ010000151.1), downstream flanked by Tn21 elements. a, d–f Entire contig shown. Attachment sites:
attI, marked as blue rhomb; attC, marked as green rectangle; hp, hypothetical protein; aspA, aspartate ammonia lyase; catB3, chloramphenicol
transferase; aph(3′)-XV, aminoglycoside phosphotransferase; xerC, tyrosine recombinase (integrase); IS1071 (Tn3 family): single element, including
transposase and flanking inverted repeats; Tn5051-like tnp region consisting of tnpA: transposase, tnpR: resolvase and tnpM: putative transposition
regulator; intI1, class 1 integron integrase; blaVIM-1, metallo-β-lactamase VIM-1; qacEΔ, quarternary ammonium compound resistance protein
(truncated); GNAT, Gcn5-related N-acetyltransferase; tniA–tniR and urf-2, tni region (Tn21-like); aac(6′)-Ib, aminoglycoside acetyltransferase; blaOXA-2,
class D β-lactamase OXA-2; ant(3″)-Ia, aminoglycoside nucleotidyltransferase; ISPa38 (Tn3 family); and an IS110 family element
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advantage for its hosts, but that it is a gene cassette ac-
cessible to diverse microbial communities and patho-
gens. Integrons are present in 20% of the sequenced γ-
proteobacterial genomes [45]. Class 1 integrons in par-
ticular have become very successful in pathogens and
highly abundant in various human-impacted environ-
ments [46, 47]. Any compatible plasmid containing a
class 1 integron could acquire the gar cassette and facili-
tate further spread. Therefore, if ecological connectivity
allows, gar can be integrated into the genomes of diverse
bacterial hosts.
So far, gar is a rare but already widely dispersed gene
in wastewater metagenomes from at least eight countries
in Europe, Asia, Africa and Australia (Table S5). Add-
itional transfer events to other pathogens are therefore
plausible. Detection of gar only in wastewater-impacted
environments, not in metagenomes from human individ-
uals, is coherent with its presence in a small proportion
of the human population. This implies that targeted in-
vestigations of wastewater would be suitable for both ini-
tial detection and monitoring, as a single sewage sample
reflects the microbiota from a very large number of indi-
viduals [48].
Conclusions
Most clinically important resistance genes are discovered
as a consequence of treatment failure or by screening
clinical isolates. The combination of integron-focused
functional metagenomics and in silico filtering of known
resistances allowed us to explore environmental samples
for already mobilised, novel resistance genes. With this
approach, we discovered gar, a new mobile resistance
gene providing high-level resistance against garosamine-
containing aminoglycosides. Despite its presence in the
clinics, gar has evaded discovery as it does not resemble
previously known aminoglycoside resistance genes. The
knowledge presented here offers possibilities for early
surveillance, actions to reduce transmission, gene-based
diagnostics and ultimately improved treatment.
Methods
Detailed material and methods with references are found
in Additional file 5.
Bacterial strains
Metagenomic library construction and functional
screenings were conducted in E. coli DH10β (NEB).
Functional verifications were performed in E. coli
C600Z1 (Expressys) and GAR-induced increases in ami-
noglycoside MICs were determined in E. coli BL21(DE3)
(Invitrogen). P. aeruginosa 105MG [33] was kindly sup-
plied by Professors C. Giske and G. Rossolini.
Metagenomic DNA samples
DNA was extracted, pooled and amplified with three sets
of primers targeting the gene cassette array of class 1
integrons from sediment samples collected from Mutha
River (Pune, Maharashtra, India) and Isakavagu/Nakka-
vagu River (Patancheru Enviro Tech Ltd. (PETL) near
Hyderabad, India) as described before [9]. In contrast to
the previously performed amplification of the same sam-
ples [9], 5′ phosphorylated primers were used to gener-
ate inserts for metagenomics libraries.
Metagenomic library preparation and functional selection
To identify mobilised novel resistance determinants,
class 1 integron gene cassette libraries were prepared
and screened following the protocol by Forsberg et al.
[3] with some modifications. The plasmid pZE21-Pbla
(pZE21-MCS1 harbouring the constitutively active pro-
moter Pbla) was linearised, dephosphorylated and ligated
with the amplified class 1 integron gene cassettes to cre-
ate the libraries, which were electroporated into E. coli
DH10β.
For functional selection, 100 μl of each metagenomic
library was plated on LB + Kan50 agar containing one of
13 different antibiotics (ciprofloxacin, trimethoprim,
gentamicin, tigecycline, chloramphenicol, nitrofurantoin,
rifampicin, cefotaxime, ertapenem, imipenem, merope-
nem, sulfamethoxazole and colistin) at three different
concentrations (4 × MIC, 8 × MIC and clinical break-
point concentration). All colonies from a single plate
were scraped off, resuspended in LB + 20% glycerol and
frozen at − 80 °C.
Amplicon-PCR and sequencing
Pooled antibiotic resistant clone libraries were used as
PCR templates to prepare amplicons with barcoded
primers that allowed allocation of the antibiotics and con-
centrations used for selecting clones. Amplicons were
combined into two pools (16 amplicons each), and se-
quencing libraries were prepared from each pool using
SMRTbell™ Template Prep Kit 1.0-SPv3. The two libraries
were sequenced on separate PacBio Sequel™ SMRT® cells
in the Science for Life Laboratories (Uppsala, Sweden).
Integron amplicon read analysis
Open reading frames were predicted using Prodigal [49]
(v2.6.3). The predicted ORFs were searched against
NCBI’s non-redundant protein database (last update
13.04.2017) and ResFinder [50] (last update 15.04.2018)
using Diamond [51] (v0.9.24.125). We defined known
ARGs as ORFs with identities greater than 95% and
coverage greater than 85% to their homologues in the
ResFinder database. Reads that contained known ARGs
responsible for the respective phenotype were filtered
out.
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To identify promising putative novel resistance genes,
a manual search of the read sets for complete ORFs that
were highly abundant in their set of reads followed.
Presence of the cassette amplification primers was re-
quired to ensure that the ORF originated from an inte-
gron and that it was solely responsible for the resistance
phenotype.
Functional verification of novel resistance genes
Resistance gene candidates were synthesised and tested
in E. coli C600Z1 pZE21-MCS1 as described earlier [9].
Subsequently, gar was inserted into pUC19, replacing
the bla gene and transformed into E. coli BL21(DE3) to
test it in an expression system without any aminoglyco-
side resistance.
MIC determination
Minimal inhibitory concentrations (MICs) were deter-
mined by broth microdilution in cation-adjusted
Mueller-Hinton medium. Serial dilutions of tested anti-
biotics were prepared in triplicate in 96-well plates and
inoculated with 5 × 105 cells/ml per well (CLSI standard
[52]) at a final volume of 200 μl. After 24 h incubation at
37 °C and 180 rpm, the optical density was measured
and MIC was defined as the lowest concentration of an
antimicrobial that reduced growth to OD650 ≤ 0.2 [53].
Whole genome sequencing
Genomic DNA was isolated using the DNeasy® Blood &
Tissue Kit (Qiagen) and sent to FIMM Technology
Centre in Helsinki, Finland, for next generation sequen-
cing. The KAPA HyperPlus Kit was used for library
preparation and paired-end sequencing was performed
on a MiSeq® (Illumina). The paired-end datasets were fil-
tered and trimmed using the Trim Galore (v0.4.4) soft-
ware. SPAdes [54] (v3.12.0) was used to assemble the
short reads into 134 contigs with a length greater than
500 bp. The regions around the gene (Fig. 4) were scaf-
folded from contigs 1, 3, 62, 83 and 89 using the previ-
ously recovered integron sequence (GenBank accession:
AJ786649.2) and by manually exploring De Bruijn graphs
with the Bandage software [55] (v0.8.1) as well as experi-
mental control by PCR.
Multi-locus sequence typing
Contigs were searched against the PubMLST database
[56]. P. aeruginosa 105MG was previously classified as
ST227 [33], but whole genome sequencing resulted in a
single nucleotide difference in the mutL allele changing
the sequence type to ST235.
Metagenome search
The abundance of gar was searched in 1251 public
metagenomic datasets (Additional file 2). Diamond [51]
(v0.9.24.125) was used to map the reads to the reference
protein with 100% identity and an ORF-length greater
than 20 amino acids. To study the genetic context
around the novel ARG, short reads from selected meta-
genomic datasets were mapped to the reference se-
quences from P. aeruginosa 105MG and Luteimonas sp.
83-4 using Bowtie 2 [57] (v2.2.9). Integron attachment
sites were detected by identifying marginal paired-end
reads using the Tablet software [58] (v1.19.05).
Phylogenetic trees
Sequences of the 1000 proteins most closely related to
GAR were collected using three iterations of PSI-BLAST
[59] on the NCBI non-redundant protein database. The
retrieved proteins, GAR and all aminoglycoside resist-
ance proteins from ResFinder were aligned with MAFFT
[60] (v7.310). The phylogenetic tree was calculated by
FastTree [61] (v2.1.9) using the maximum likelihood al-
gorithm, Jones-Taylor-Thornton model, with 1000 boot-
straps. Protein accession numbers and the full version of
the tree are available in Additional files 3 and 4. The
Interactive Tree Of Life (iTOL v4) online tool [62] was
used to prepare the phylogenetic tree for display.
Protein model
The I-TASSER server for protein structure and function
prediction was used to create models of GAR [63]. The
model with the highest confidence score (C-score, −
0.21) is shown. DeepView/Swiss-PdbViewer [64] (v4.1.0)
was used to create the ribbon presentation.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s40168-020-00814-z.
Additional file 1. Supplementary Material. Table S1. Cation-
dependency: MIC gentamicin [μg/ml] of GAR in different media. Table
S2. Chemical structure of the tested aminoglycosides and resistance
profile conveyed by GAR. Table S3. Predicted and determined
resistances of Pseudomonas aeruginosa 105MG. Table S4. Predicted
resistances of Luteimonas sp. 83–4. Table S5. Occurrence of gar in 1251
metagenomic datasets.
Additional file 2. List of metagenomes searched for the presence of gar.
Additional file 3. Accession numbers of protein sequences used to
calculate the phylogenetic tree.
Additional file 4. Phylogenetic tree of AMEs, GAR and the most closely
related proteins in Newick format.
Additional file 5. Detailed material and methods.
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